SL28 Coffee (Coffea arabica)

SL28 coffee (Coffea arabica) is a Kenyan cultivar containing 1-2% caffeine by dry weight that provides alertness through adenosine receptor antagonism. It contains chlorogenic acids and other coffee polyphenols but lacks specific clinical research on health benefits.

Origin & History

SL28 is a cultivar variant of Coffea arabica (Arabica coffee) selected in the 1930s at Scott Agricultural Laboratories in Kenya from a drought-resistant Bourbon-type variety originating from Tanzania. Grown primarily in Kenya's highlands and other high-altitude regions, it is prized for its resilience to drought via a deep root system and distinctive sensory qualities including citric acidity and blackcurrant notes.

Historical & Cultural Context

SL28 has no documented historical use in traditional medicine systems, as it was developed in the 1930s for agricultural yield and cup quality, not medicinal purposes. While general coffee has traditional uses in Ethiopian and Yemeni systems for stimulation since the 15th century, SL28 postdates these by centuries as a modern Kenyan agricultural cultivar.

Health Benefits

• No specific health benefits documented - No clinical trials or human studies exist for SL28 coffee specifically
• General Coffea arabica caffeine content (~1-2% dry weight) - May provide alertness through adenosine receptor antagonism (evidence quality: not studied for SL28)
• Contains chlorogenic acids (~5-10%) common to arabica varieties - Potential antioxidant properties (evidence quality: not studied for SL28)
• Deep root system enables drought resistance - Agricultural benefit only, no human health implications documented
• No SL28-specific biomedical research - All health claims would be extrapolated from general coffee research

How It Works

Caffeine in SL28 coffee acts as an adenosine A1 and A2A receptor antagonist, blocking adenosine-induced drowsiness and promoting wakefulness. Chlorogenic acids function as antioxidants by scavenging reactive oxygen species and may inhibit glucose-6-phosphatase activity. The polyphenolic compounds also modulate inflammatory pathways through NF-κB inhibition.

Scientific Research

No clinical trials, RCTs, or meta-analyses specific to SL28 coffee were identified in biomedical literature. PubMed searches yield no SL28-specific human trials, with research focusing solely on its agronomic and sensory qualities rather than human health outcomes.

Clinical Summary

No clinical trials have specifically examined SL28 coffee's health effects. General Coffea arabica research shows caffeine doses of 100-400mg improve alertness and cognitive performance in healthy adults. Chlorogenic acid studies typically use 140-1200mg doses for metabolic benefits, but SL28's specific chlorogenic acid content and bioavailability remain unstudied. Evidence quality for SL28-specific benefits is insufficient.

Nutritional Profile

SL28 Coffee (Coffea arabica) nutritional data is reported per 100g roasted ground coffee unless otherwise noted. Macronutrients: Protein ~13-15g (rich in melanoidins and degraded proteins post-roasting; raw green bean protein ~10-13g), Carbohydrates ~28-30g (predominantly non-digestible polysaccharides including galactomannans ~20% and arabinogalactans ~10% in green bean; sucrose largely destroyed during roasting to <1g in dark roast vs ~6-9g in green bean), Fat ~12-15g (primarily linoleic acid, palmitic acid; diterpenes cafestol and kahweol ~0.5-1.0g present in unfiltered preparations; paper filtration removes ~97% of diterpenes). Fiber: ~33-40g (primarily insoluble; significant portion survives brewing as spent grounds, minimal transfer to brewed cup ~1-2g/250ml). Bioactive Compounds: Caffeine ~1.0-1.7% dry weight in green bean (SL28 historically noted toward moderate-high end of arabica range ~1.2-1.6%); Chlorogenic acids (CGAs) ~5-10% dry weight in green bean, predominantly 5-caffeoylquinic acid (5-CQA); CGA content reduced 50-70% during medium-dark roasting; brewed cup yields ~150-350mg CGAs per 250ml depending on roast and brew method. Trigonelline ~0.6-1.2% dry weight (partially converts to niacin/nicotinic acid during roasting, yielding ~4-5mg niacin equivalents per cup). Melanoidins: 25-30% of roasted coffee dry weight; formed via Maillard reactions; exhibit antioxidant and prebiotic properties. Minerals per 100g roasted: Potassium ~2000-2500mg (highest mineral; significant transfer to brew ~116mg/250ml cup), Magnesium ~180-200mg (~12mg/cup), Manganese ~1.0-2.0mg, Phosphorus ~160mg, Calcium ~120mg, Iron ~4-5mg (low bioavailability due to chlorogenic acid chelation, estimated 50-70% reduction in non-heme iron absorption). Vitamins: Riboflavin (B2) ~0.2mg/100g, Niacin ~10-40mg/100g (highly variable; roasting-dependent conversion from trigonelline), Pantothenic acid trace amounts. Brewed beverage context (per 250ml, medium roast, drip method): Caffeine ~80-120mg, CGAs ~200-300mg, Potassium ~116mg, Magnesium ~12mg, Niacin ~0.5mg. Bioavailability notes: CGAs show 33% bioavailability from coffee matrix; colonic microbiota metabolize remaining CGAs to dihydrocaffeic and dihydroferulic acids; caffeine bioavailability near 100% from aqueous brew; diterpene content negligible in filtered drip coffee but substantial in French press (~6mg cafestol/cup) or espresso (~1-2mg cafestol/shot). SL28-specific compositional data is extremely limited in published literature; values represent Coffea arabica species norms with SL28 likely falling within typical arabica ranges given its genetic background as a Tanganyika-derived drought-resistant selection.

Preparation & Dosage

No clinically studied dosage ranges exist for SL28 in any form, as it lacks biomedical clinical data and is not used as a standardized supplement. Typical consumption mirrors general brewed coffee (1-3 cups/day), but without standardization or health-focused dosing studies. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

No synergistic ingredients studied with SL28 specifically

Safety & Interactions

SL28 coffee safety profile likely mirrors general coffee consumption, with moderate intake (3-4 cups daily) considered safe for most adults. Caffeine can interact with medications like warfarin, increasing bleeding risk, and may reduce absorption of iron and certain antibiotics. Pregnant women should limit intake to 200mg caffeine daily due to potential fetal development risks. Individual sensitivity varies, with some experiencing anxiety, insomnia, or digestive upset.